Advances in Cancer Research by Paul Fisher

Advances in Cancer Research

byPaul Fisher, Paul Fisher, Kenneth D Tew

Other | May 10, 2012

not yet rated|write a review

Pricing and Purchase Info

$147.19 online 
Earn 736 plum® points

In stock online

Ships free on orders over $25

Not available in stores


Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of topics.

  • 113th volume of Advances in Cancer Research
  • Expert authors
  • Chapters on topics including microRNA regulatory network, multifaceted oncoprotein tax, and underlying chromosomal translocations

About The Author

Professor & Chairman, Dept of Cell & Molecular Pharmacology John C. West Chair of Cancer Research, Medical University of South Carolina, USAThe Tew laboratory maintains an interest in using redox pathways as a platform to develop therapeutic strategies through drug discovery/development and biomarker identification. We interrogate how ...
Spring Persistence With Hibernate
Spring Persistence With Hibernate

by Paul Fisher


In stock online

Not available in stores

Emerging Applications of Molecular Imaging to Oncology
Emerging Applications of Molecular Imaging to Oncology

by Martin Pomper


Available for download

Not available in stores

Immunotherapy of Cancer
Immunotherapy of Cancer

by Xiang-Yang Wang


Available for download

Not available in stores

Shop this author

Details & Specs

Title:Advances in Cancer ResearchFormat:OtherDimensions:304 pages, 1 × 1 × 1 inPublished:May 10, 2012Publisher:Elsevier ScienceLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0123978416

ISBN - 13:9780123978417

Customer Reviews of Advances in Cancer Research


Extra Content

Table of Contents

      1. The AID dilemma: infection, or cancer?
      2. The microRNA regulatory network in normal- and HTLV-1-transformed T cells
      3. The multifaceted oncoprotein Tax: Sub-cellular localization, post-translational modifications and NF-κB activation
      4. Lynch or not Lynch? Is that always a question?
      5. Activation induced deaminase in antibody diversification and chromosome translocation
      6. Opportunities and challenges in tumor angiogenesis research: back and forth between bench and bed
      7. Molecular Logic Underlying Chromosomal Translocations, Random or non-Random?